Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice-Reference-Cited by-同舟云学术

Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice

Published:2016-03-14 Issue:6 Volume:28 Page:891-899
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterol. Motil.

Author:

Li X.-H.¹,Lin M.-L.¹,Wang Z.-L.¹,Wang P.¹,Tang H.-H.¹,Lin Y.-Y.¹,Li N.¹,Fang Q.¹,Wang R.¹

Affiliation:

1. Key Laboratory of Preclinical Study for New Drugs of Gansu Province; Institute of Physiology; School of Basic Medical Sciences; Lanzhou University; Lanzhou China

Funder

National Natural Science Foundation of China

Program for New Century Excellent Talents in University

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nmo.12789/fullpdf

Reference30 articles.

1. Hemopressin is an inverse agonist of CB1 cannabinoid receptors;Heimann;Proc Natl Acad Sci U S A,2007

2. Novel endogenous peptide agonists of cannabinoid receptors;Gomes;FASEB J,2009

3. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice;Dodd;J Neurosci,2010

4. Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(alpha)], an N-Terminally Extended Hemopressin Peptide;Han;The Journal of Pharmacology and Experimental Therapeutics,2014

5. Modulation of the cannabinoid receptors by hemopressin peptides;Bomar;Life Sci,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects;Neuropeptides;2024-10

2. OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects;Anesthesia & Analgesia;2022-12-01

3. Characterization of pepcan-23 as pro-peptide of RVD-hemopressin (pepcan-12) and stability of hemopressins in mice;Advances in Biological Regulation;2021-05

4. Innovations in noninvasive methods for measuring gastrointestinal motility in mice;Translational and Regulatory Sciences;2021

5. VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects;Neuropharmacology;2020-09